Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL

Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare type ... Read More